Urology
Guideline: Renal Transplantation
26 Jul, 2018 | 17:42h | UTC
Review: Prevention and Management of Urosepsis Triggered by Ureteroscopy
20 Jul, 2018 | 01:55h | UTCPrevention and management of urosepsis triggered by ureteroscopy – Research and Reports in Urology (free)
Randomized Trial: Antibiotic Prophylaxis for Patients with Neurogenic Bladder and Repeated Urinary Tract Infections
6 Jul, 2018 | 09:47h | UTCInvited Commentary: Preventing urinary tract infections in patients with neurogenic bladder (free)
Randomized Trial: Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer
6 Jul, 2018 | 09:34h | UTCEnzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer – New England Journal of Medicine (link to abstract – $ for full-text)
Related Perspective: Metastasis-free Survival — A New End Point in Prostate Cancer Trials – New England Journal of Medicine (free)
Commentaries: Enzalutamide: Now Also for Earlier Use in Prostate Cancer? – Medscape (free registration required) AND Enzalutamide Improves Outcomes for Aggressive Prostate Cancer – MPR (free) AND Enzalutamide Postpones Metastasis for a Subset of High-Risk Patients With Prostate Cancer – Cancer Therapy Advisor (free)
Cohort Study: Infectious and Noninfectious Complications Associated with Indwelling Urethral Catheters
6 Jul, 2018 | 09:25h | UTCCommentary: Foleys Aren’t Fun: Patient Study Shows Catheter Risks – University of Michigan, via NewsWise (free)
“More than half of patients surveyed while they had a urinary catheter, and again weeks later, reported a complication – and infections were only part of the problem” (from NewsWise)
Cohort Study: Percutaneous Ablation Versus Partial and Radical Nephrectomy for T1a Renal Cancer
29 Jun, 2018 | 02:34h | UTCPercutaneous Ablation Versus Partial and Radical Nephrectomy for T1a Renal Cancer: A Population-Based Analysis – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentaries: Percutaneous ablation may be preferred to nephrectomy for selected patients with early-stage renal cancer – ACP Internist (free) AND New Findings Support Ablation for Small Renal Tumors – Renal & Urology News (free)
Related Meta-Analysis: Radiofrequency ablation versus partial nephrectomy for treatment of renal masses: A systematic review and meta-analysis – The Kaohsiung Journal of Medical Sciences (free) AND Radiofrequency Ablation Versus Partial Nephrectomy in Treating Small Renal Tumors: A Systematic Review and Meta-Analysis – Medicine (free)
“Percutaneous ablation for T1a renal cancer has similar 5-year survival rates to radical nephrectomy but with far fewer 30-day complications and less kidney failure (via @AnnalsofIM see Tweet)
Randomized Trial: Robot-Assisted Radical Cystectomy No Better Than Open Radical Cystectomy in Patients with Bladder Cancer
29 Jun, 2018 | 02:18h | UTCRobot-assisted radical cystectomy versus open radical cystectomy in patients with bladder cancer (RAZOR): an open-label, randomised, phase 3, non-inferiority trial – The Lancet (link to abstract – $ for full-text)
Commentaries: Robotic, Open Cystectomy Offer Comparable Bladder Cancer Outcomes – Renal & Urology News (free) AND RAZOR study: No differences in robotic vs open surgery for bladder cancer – Coloproctology News (free) AND Robotic surgery is no better than traditional surgery, bladder cancer study finds – The Washington Post (free)
Randomized Trial: Prostatic Artery Embolization vs Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia
19 Jun, 2018 | 22:30h | UTCCommentary: Prostatic artery embolisation: time to improve collaboration – The BMJ Opinion (free)
Randomized Trial: Medical Expulsive Therapy Not Effective for Kidney Stone Passage
18 Jun, 2018 | 23:18h | UTCEffect of Tamsulosin on Passage of Symptomatic Ureteral Stones: A Randomized Clinical Trial – JAMA Internal Medicine (free for a limited period)
Editorial: Medical Expulsive Therapy for Ureteral Stones—Stone Age Medicine (free)
Commentaries: Recent Clinical Trial Finds Tamsulosin Not Effective in Kidney Stone Passage – George Washington University, via NewsWise (free) AND For Passing Smaller Ureteral Stones, Tamsulosin May Be No Better Than Placebo – NEJM Physician’s First Watch (free)
Cohort Study: Erectile Dysfunction as an Independent Predictor of Future Cardiovascular Events
15 Jun, 2018 | 01:52h | UTCAHA News Release: Erectile dysfunction means increased risk for heart disease, regardless of other risk factors (free)
Commentaries: Men With Erectile Dysfunction Are Twice As Likely to Have Heart Disease, Study Says – TIME (free) AND Erectile Dysfunction Linked To Higher Chances Of Heart Problems In Men – Medical Daily (free)
Research: Biparametric MRI (simpler, faster) May Be Used to Exclude Aggressive Disease and Avoid Unnecessary Biopsies in Men with Clinical Suspicion of Prostate Cancer
15 Jun, 2018 | 01:11h | UTCCommentary: Biparametric MRI Helps Rule Out Significant Prostate Cancers – NEJM Physician’s First Watch (free)
Related: MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis (link to abstract and commentaries)
ASCO 2018: Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma
7 Jun, 2018 | 02:21h | UTCEditorial: Cytoreductive Nephrectomy — Patient Selection Is Key (free)
Commentaries: 2018 ASCO: Carmena Trial Compares Nephrectomy Plus Adjuvant Sunitinib vs Sunitinib Alone in Metastatic RCC – The ASCO Post (free) AND In Advanced Kidney Cancer, Surgery No Longer Sole Standard of Care – Medscape (free registration required)
AUA/ASTRO/SUO Guideline: Clinically Localized Prostate Cancer
6 Jun, 2018 | 21:49h | UTCPart I: Risk Stratification, Shared Decision Making, and Care Options – The Journal of Urology (free)
Part II: Recommended Approaches and Details of Specific Care Options – The Journal of Urology (free)
ASCO 2018: Some Patients With Prostate Cancer Have Good Results With Immunotherapy
6 Jun, 2018 | 21:37h | UTCCommentaries: First Major Trial Of Keytruda For Prostate Cancer Shows It Works, But Only For A Minority Of Men – Forbes (free)
Guideline: Peyronie’s Disease and Congenital Penile Curvature
29 May, 2018 | 18:26h | UTC
Systematic Review: Non-pharmacological Interventions for Treating Chronic Prostatitis/Chronic Pelvic Pain Syndrome
24 May, 2018 | 22:56h | UTCNon-pharmacological interventions for treating chronic prostatitis/chronic pelvic pain syndrome – Cochrane Library (free)
Summary: Intervention for treating chronic prostatitis and chronic pelvic pain in men – Cochrane Library (free)
Consensus Statement: Management of Nocturnal Enuresis
24 May, 2018 | 22:44h | UTC
Meta-Analysis: Smoking and Death from Prostate Cancer
24 May, 2018 | 22:35h | UTCAssociation of Smoking Status With Recurrence, Metastasis, and Mortality Among Patients With Localized Prostate Cancer Undergoing Prostatectomy or Radiotherapy: A Systematic Review and Meta-analysis – JAMA Oncology (free for a limited period)
Commentaries: Smoking and Death From Prostate Cancer JAMA Oncology (free for a limited period) AND Current Smokers at Risk for Worse Prostate Cancer Outcomes – Renal & Urology News (free)
Retrospective Cohort: More Patients Choosing Active Surveillance for Low-Risk Prostate Cancer
23 May, 2018 | 12:17h | UTCUse of Conservative Management for Low-Risk Prostate Cancer in the Veterans Affairs Integrated Health Care System From 2005-2015 – JAMA (free for a limited period)
Commentaries: VA health care successfully reduces ‘rush to treatment’ rates for low-risk prostate cancer – eCancer News (free) AND Watching but not treating cancer can be hard. Sometimes it’s the right approach – The Washington Post (a few articles per month are free)
Guideline: Surgical Management of Lower Urinary Tract Symptoms attributed to BPH
21 May, 2018 | 13:14h | UTCCommentary: AUA: Guideline on Surgical Management of BPH-Related Lower Urinary Tract Symptoms – MPR (free)
Randomized Trial: Intravesical Gemcitabine Following Resection of Suspected Low-Grade Non–Muscle-Invasive Bladder Cancer
16 May, 2018 | 01:16h | UTCEffect of Intravesical Instillation of Gemcitabine vs Saline Immediately Following Resection of Suspected Low-Grade Non–Muscle-Invasive Bladder Cancer on Tumor Recurrence: SWOG S0337 Randomized Clinical Trial – JAMA (link to abstract – $ for full-text)
Commentaries: Intravesical Gemcitabine Therapy Cuts Bladder Cancer Recurrence – MPR (free) AND Simple post-surgery step reduces bladder cancer recurrence – SWOG, via EurekAlert (free)
Case Control Study: Oral Antibiotic Exposure and Kidney Stone Disease
16 May, 2018 | 00:56h | UTCOral Antibiotic Exposure and Kidney Stone Disease – Journal of the American Society of Nephrology (link to abstract – $ for full-text)
Commentaries: Study suggests oral antibiotics may increase kidney stone risk – CIDRAP (free) AND Antibiotics May Raise the Risk for Kidney Stones – The New York Times (free) AND Oral Antibiotics May Raise Risk of Kidney Stones – Children’s Hospital of Philadelphia, via NewsWise (free)
Study: Financial Conflicts of Interest Among Authors of Urology Guidelines
14 May, 2018 | 04:49h | UTC“59% Urology Guideline writers received payments from companies AND 37% provided inaccurate COIs forms” (via @daviesbj see Tweet)
AUA Guideline: Erectile Dysfunction
11 May, 2018 | 02:56h | UTCErectile Dysfunction – American Urology Association (2018) (free)
USPSTF Recommendation Statement: Screening for Prostate Cancer
10 May, 2018 | 17:46h | UTCScreening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement – JAMA (free)
Editorials: Prostate-Specific Antigen (PSA) Screening for Prostate Cancer: Revisiting the Evidence (free) AND USPTF Prostate Cancer Screening Recommendations—A Step in the Right Direction (free) AND Implications of the New USPSTF Prostate Cancer Screening Recommendation—Attaining Equipoise (free) AND Prostate Cancer Screening—A New Recommendation for Meaningful Physician-Patient Conversations (free)
Author Interview: USPSTF Recommendation: Screening for Prostate Cancer (free)
Video Summary: PSA Screening for Prostate Cancer: The 2018 USPSTF Recommendation Statement (free)
Infographic with key Facts: Is Prostate Cancer Screening Right for You? Understanding the Potential Benefits vs. Harms for Men 55-69 (free)
Commentary: Prostate cancer screening: the decision is up to you – Reuters (free)